Bladder Cancer

BLADDER CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Thawing Frozen Cancer Drug Labels

As medical care rapidly evolves, there’s really no debate over the potential for drug labels to become outdated, particularly in the high stakes world of cancer treatment. The question is how best to ameliorate the problem, while still protecting the process from financial and other conflicts. Off-label prescribing of cancer drugs is common, occurring 30%…
Adding Gemcitabine at the Time of Resection Reduces Recurrence, Cost in Early-Stage Bladder Cancer

Though early-stage bladder cancer is infrequently fatal, the decrease in recurrence rates has a meaningful impact on the quality of life for patients as well as treatment costs.
Muscle-Invasive Bladder Cancer: The Evolving Treatment Landscape

Patients diagnosed with MIBC are at a significant risk for death — which has not greatly improved in the last few decades.
Bladder Cancer: Immunotherapies, Combination Therapies, and Current Research

Several promising drugs have been approved for the treatment of bladder cancer within the phase year, but combination therapies may be still more effective.
Bladder Cancer Treatment Is Being Revolutionized by Immunotherapy

Clinical trials and drug approvals in the past several years have dramatically improved bladder cancer treatment.

VIDEO SERIES

Immunotherapy for Advanced Bladder Cancer: The Next Frontier

Bladder-sparing Strategies

Intravesical Therapy: When Bacillus Calmette-Guerin Fails

AUA Guidelines: Non-muscle Invasive Bladder Cancer

Bladder Cancer Biomarkers: New and Old

Current Research and New Treatments

PD-L1 Inhibitors Changing the Standard of Care

The Emergence of Personalized Medicine

BLADDER CANCER NEWS

For Patients With Bladder Cancer, Inadequate Biopsies May Increase 5-Year Mortality

High Monocyte-to-Lymphocyte Ratio Predictive of OS in Advanced Gallbladder Cancer

March 14, 2019

Cancer Therapy Advisor spoke with Thomas J. Walsh, MD to discuss how he diagnoses and treats patient

Adding Chemotherapy to Radiation Post-Radical Cystectomy Improves Survival in Urothelial Carcinoma

February 15, 2019

Research and treatment of myeloma are beginning to focus on quality of life in addition to survival.

Radiation, Chemotherapy Not Beneficial in Localized Upper Tract Urothelial Carcinoma

February 15, 2019

Evidence suggests that starting on systemic drug therapy immediately may be the best approach for so

Radical Cystectomy Superior to Trimodal Therapy for Muscle-Invasive Bladder Cancer

February 15, 2019

Several promising drugs have been approved for the treatment of bladder cancer within the phase year

Pembrolizumab Shows Promise for BCG-Unresponsive Bladder Cancer

February 15, 2019

Next post in Bladder Cancer

Thawing Frozen Cancer Drug Labels